Preventing prolonged antibiotic therapy by active implementation of switch guidelines;Onnodig lange intraveneuze antibioticatherapie voorkomen door actieve implementatie van switchrichtlijnen

Nederlands Tijdschrift voor Geneeskunde

Volumn 148, Issue 5, 2004, Pages 222-226

  Handoko, K B ^a,b,c   Van Asselt, G J ^a,b   Overdiek, J W P M ^a  

^a MEDICAL CENTER HAAGLANDEN   (Netherlands)

^b Afd Ziekenhuisapotheek ^*  (Netherlands)

^c Ziekenhuisapotheek Noordoost Brabant   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; CLINICAL PRACTICE; CONFIDENCE INTERVAL; DRUG EFFICACY; FEEDBACK SYSTEM; HOSPITAL DEPARTMENT; HUMAN; LEGIONELLA; LONG TERM CARE; MEDICAL EDUCATION; NETHERLANDS; NONHUMAN; OPEN STUDY; PRACTICE GUIDELINE; PROSPECTIVE STUDY; PSEUDOMONAS; SAFETY; STAPHYLOCOCCUS AUREUS; SUPPORT GROUP; TEAMWORK; TIME;

ADMINISTRATION, ORAL; ANTI-BACTERIAL AGENTS; COSTS AND COST ANALYSIS; HOSPITALS; HUMANS; INFECTION; INFUSIONS, INTRAVENOUS; INTERNAL MEDICINE; NETHERLANDS; ORTHOPEDICS; PRACTICE GUIDELINES; PROSPECTIVE STUDIES; PULMONARY DISEASE (SPECIALTY); RISK FACTORS; SURGERY; TIME FACTORS;

EID: 0842329137     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Chan R, Hemeryck L, O'Regan M. Clancy L, Feely J. Oral versus intravenous antibiotics for community acquired lower respiratory tract infection in a general hospital: open, randomised controlled trial. BMJ 1995;310:1360-2.
2. Ahkee S, Smith S, Newman D, Ritter W, Burke J, Ramirez JA. Early switch from intravenous to oral antibiotics in hospitalized patients with infections: a 6-month prospective study. Pharmacotherapy 1997; 17:569-75.
3. Vallejo C, Caballero MD, Garcia-Sanz R, Hernandez JM, Vazquez L, Canizo MC, et al. Sequential intravenous-oral ciprofloxacin plus amoxycillin/ clavulanic acid shortens hospital stay in infected non severe neutropenic patients. Hematol Cell Ther 1997;39:223-7.
4. Ramirez JA, Vargas S, Ritter GW, Brier ME, Wright A, Smith S, et al. Early switch from intravenous to oral antibiotics and early hospital discharge: a prospective observational study of 200 consecutive patients with community-acquired pneumonia. Arch Intern Med 1999;159:2449-54.
5. Cohn SM, Lipsett PA, Buchman TG, Cheadle WG, Milsom JW, O'Marro S, et al. Comparison of intravenous/oral ciprofloxacin plus metronidazole versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections. Ann Surg 2000;232:254-62.
6. Sevinç F, Prins JM, Koopmans RP, Langendijk PNJ, Bossuyt PMM, Dankert J, et al. Vroege omzetting van intraveneuze naar orale antibiotica bevorderd door invoering van een richtlijn in een opleidingsziekenhuis. Ned Tijdschr Geneeskd 1999;143:2370-4.
7. Hamilton-Miller JMT. Switch therapy: the theory and practice of early change from parenteral to non-parenteral antibiotic administration. Clin Microbiol Infect 1996;2:12-9.
8. Gyssens IC, Lennards CA, Hekster YA, Meer JWM van der. Cost of hospital antimicrobial chemotherapy. A method for global cost calculation. Pharm Weekbl Sci 1991;13:248-53.
9. Burnett KM, Scott MG, Kearney PM, Humphreys WG, McMillen RM. The identification of barriers preventing the successful implementation of a surgical prophylaxis protocol. Pharm World Sci 2002:24:182-7.